Cisplatin for Cancer: Key Facts and Insights

Cisplatin for Cancer: What Patients Need to Know

Cisplatin for Cancer: What Patients Need to Know. Learn how cisplatin works, which cancers it treats, its potential benefits, kidney, nerve, and hearing risks, and questions to ask before treatment.

Cisplatin is one of the oldest, most powerful, and most widely used chemotherapy drugs in modern cancer treatment. It has helped transform the treatment of several cancers—most dramatically testicular cancer—but its effectiveness comes with potentially serious short- and long-term side effects.

For a newly diagnosed cancer patient, the important question isn’t simply whether cisplatin “works.”

The more useful questions are:

How effective is cisplatin for my particular cancer?
What are the potential benefits?
What are the short- and long-term risks?
How can kidney, nerve and hearing damage be monitored or reduced?
Are there situations in which another platinum drug, such as carboplatin, might be preferable?
What should I know before agreeing to treatment?

This article examines the potential benefits, risks, and trade-offs of cisplatin chemotherapy.

Important: Cisplatin can be curative for some cancers, but it can also cause serious and sometimes permanent toxicity. Decisions about cisplatin should be individualized with your oncology team.

I am a long-term survivor of an incurable blood cancer called multiple myeloma. Conventional chemo regimens did little for me other than create short- and long-term side effects.

My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.

I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.

Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer.

Good luck,

David Emerson

Chemotherapy for Breast Cancer: What Patients Need to Know

Cisplatin: What Can You Expect?

Concepts Central to Managing Your Cancer-

What Is Cisplatin?

Cisplatin is a platinum-based chemotherapy drug that has been used in cancer treatment since its FDA approval in 1978.

It is sometimes described as an “alkylating-like” chemotherapy drug. Technically, however, cisplatin is a platinum coordination complex rather than a traditional alkylating agent.

Its anticancer activity comes primarily from its ability to interact with DNA.

Once activated inside cells, cisplatin forms platinum-DNA adducts, particularly DNA crosslinks. These lesions interfere with DNA replication and transcription and can ultimately trigger cancer-cell death.

In simple terms

Cisplatin damages cancer-cell DNA so extensively that the cell can no longer successfully reproduce or survive.

Unfortunately, cisplatin can also damage healthy cells. That is the fundamental trade-off behind many of its side effects.

Which Cancers Are Treated With Cisplatin?

Cisplatin is used in many chemotherapy combinations.

The FDA labeling specifically includes advanced:

Cisplatin is also widely incorporated into treatment regimens for other cancers, depending on cancer type, stage, and treatment intent.

Examples include some:

Cisplatin may be used:

Before surgery (neoadjuvant therapy)
After surgery (adjuvant therapy)
As definitive chemotherapy
Concurrently with radiation
For metastatic disease
In combination with other chemotherapy drugs
In selected curative-intent regimens

The fact that cisplatin is used in many cancers does not mean that cisplatin is equally effective for every cancer.

The benefit depends heavily on the cancer’s biology and the treatment regimen in which cisplatin is used.

Why Is Cisplatin Such an Important Cancer Drug?

Cisplatin has an unusual combination of characteristics.

It is:

Powerful.
Relatively inexpensive compared with many newer cancer drugs.
Well studied.
Effective against multiple cancers.

And, in some cancers, potentially curative.

Perhaps the most dramatic example is testicular cancer.

Cisplatin-based chemotherapy helped transform metastatic testicular cancer from a frequently fatal disease into one of the most curable advanced solid tumors.

Long-term studies of cisplatin-based chemotherapy demonstrate just how substantial this therapeutic benefit can be.

This is an important perspective when discussing cisplatin’s toxicity.

A chemotherapy drug that can cause permanent nerve damage or hearing loss may nevertheless be an extraordinarily good trade-off when the alternative is a substantially higher risk of dying from cancer.

The Potential Benefits of Cisplatin

1. It Can Be Curative

Perhaps the most important benefit is also the easiest to overlook.

For some patients, cisplatin isn’t simply intended to slow cancer progression.

It can be part of a curative treatment regimen.

This is particularly important in some germ-cell cancers, including testicular cancer.

Historical studies helped establish the extraordinary curative potential of cisplatin-based chemotherapy in metastatic germ-cell cancer.

2. Cisplatin Can Produce Powerful Tumor Responses

Cisplatin creates extensive DNA damage.

Cancer cells that cannot adequately repair that damage may undergo apoptosis, or programmed cell death.

This helps explain why cisplatin can produce dramatic responses in particularly cisplatin-sensitive cancers.

3. It Can Work With Other Cancer Treatments

Cisplatin is frequently used in combination chemotherapy rather than by itself.

Combining cisplatin with other agents can exploit different mechanisms of cancer-cell damage.

It may also be combined with radiation therapy or newer treatments such as immune checkpoint inhibitors depending on the cancer and treatment setting.

Research continues to investigate combinations of platinum chemotherapy with immunotherapy and PARP inhibitors.

The Major Disadvantages of Cisplatin

The biggest problem with cisplatin is not that it fails to kill cancer cells.

It is that it can also damage healthy tissues.

The FDA labeling carries prominent warnings concerning:

Other important toxicities include hearing damage, electrolyte abnormalities, reproductive toxicity and heart damage.

1. Cisplatin and Kidney Damage

Nephrotoxicity is one of the most important cisplatin risks.

Cisplatin can injure the kidneys, and the risk can increase with cumulative exposure.

Severe kidney toxicity can include acute kidney injury and reduced kidney function.

This is one reason patients receiving cisplatin are carefully monitored with laboratory testing.

The prescribing information specifically recommends adequate hydration and monitoring of renal function and electrolytes.

Hydration matters

Hydration before and after cisplatin administration is an important component of kidney-protection strategies.

Research has also investigated magnesium supplementation and diuresis as ways of reducing cisplatin-associated kidney injury.

A useful patient question

Ask your oncologist:

“How are you going to protect and monitor my kidneys during cisplatin treatment?”

This is a particularly important question for patients who already have impaired kidney function or other factors that increase renal risk.

2. Cisplatin Can Cause Peripheral Neuropathy

Cisplatin can damage peripheral nerves.

Symptoms may include:

Tingling
Numbness
Burning sensations
Pain
Altered sensation in the hands or feet
Difficulty with balance in more severe cases

The FDA describes cisplatin-associated peripheral neuropathy as dose-related, with toxicity potentially becoming more severe after repeated courses.

For some patients, neuropathy improves after chemotherapy ends.

For others, symptoms can persist.

This is one reason patients should report new neurological symptoms rather than assuming they simply have to “tough it out.”

3. Cisplatin Can Cause Hearing Loss and Tinnitus

This is one of cisplatin’s most distinctive toxicities.

Cisplatin can cause:

Tinnitus
Hearing loss
High-frequency hearing loss
Vestibular problems
In severe cases, deafness

A systematic review and meta-analysis found that hearing loss is a substantial problem among patients exposed to platinum chemotherapy, with higher prevalence associated with cisplatin than carboplatin in the analyzed studies.

Importantly, hearing damage can be cumulative.

Patients should tell their medical team about:

Ringing in the ears
Difficulty hearing conversations
Difficulty hearing high-pitched sounds
A sensation of ear fullness
Changes in balance

Baseline and follow-up audiology may be appropriate, particularly for patients at elevated risk.

Research into methods of preventing cisplatin-related hearing loss continues. A 2025 systematic review and meta-analysis found that currently studied preventive interventions have not established a broadly effective strategy for adults.

4. Severe Nausea and Vomiting

Cisplatin is highly emetogenic.

In other words, cisplatin can cause severe nausea and vomiting.

Fortunately, modern supportive oncology has made this side effect much more manageable.

Patients are generally given preventive anti-nausea medications rather than waiting until severe vomiting develops.

The current prescribing information specifically recommends highly effective antiemetic treatment.

Patients should not hesitate to tell their oncology team if nausea or vomiting isn’t adequately controlled.

5. Myelosuppression

Cisplatin can suppress bone marrow function.

This can contribute to reduced:

Red blood cells
White blood cells
Platelets

Consequences may include:

Anemia
Increased infection risk
Fatigue
Bleeding or bruising

Severe myelosuppression can be dangerous, which is why blood counts are monitored during treatment.

6. Electrolyte Abnormalities

Cisplatin can cause renal electrolyte wasting.

Potential abnormalities include:

Low magnesium
Low potassium
Low calcium
Low sodium
Low phosphate

Hypomagnesemia is particularly important because it may require supplementation.

This is another reason laboratory monitoring is an important part of cisplatin treatment.

7. Fertility and Reproductive Health

Cisplatin and cisplatin-containing chemotherapy can affect reproductive function.

For younger patients, fertility preservation should therefore be discussed before treatment begins whenever possible.

Depending on the patient, this may include:

Sperm banking
Egg or embryo preservation
Other fertility-preservation strategies

This conversation is particularly important because fertility preservation may become considerably more difficult after treatment has started.

8. Cisplatin Can Cause Long-Term Health Effects

One of the most important lessons about cisplatin is that finishing chemotherapy does not necessarily mean every consequence of treatment ends immediately.

Some survivors experience persistent:

Neuropathy
Hearing problems
Kidney dysfunction
Cardiovascular or metabolic complications
Fertility problems

Long-term survivorship therefore deserves attention.

The goal shouldn’t simply be:

“Finish chemotherapy.”

It should be:

“Finish the most effective treatment possible while preserving long-term health and quality of life.”

Cisplatin vs. Carboplatin: Is One Better?

Patients sometimes hear that carboplatin is “safer” than cisplatin.

The reality is more complicated.

Cisplatin and carboplatin are both platinum-based chemotherapy drugs, but their toxicity profiles differ.

In broad terms:

Cisplatin	Carboplatin
Often more nephrotoxic	Generally less kidney toxicity
More ototoxic	Generally less ototoxic
More neurotoxic	Generally less neurotoxic
More severe nausea/vomiting	Generally less emetogenic
Can cause significant electrolyte abnormalities	Different toxicity profile
Often particularly important in curative regimens	Used when appropriate depending on cancer
Can be highly effective	Can also be highly effective

But “less toxic” does not automatically mean “better.”

For some cancers, cisplatin has an important therapeutic advantage and substituting carboplatin may reduce treatment effectiveness.

Therefore, the choice should be based on the patient’s cancer, treatment objective, kidney function, hearing status, age, overall health and other individual factors.

Who May Need Particular Caution With Cisplatin?

A patient’s oncology team may pay particular attention to cisplatin risks when a patient has:

Pre-existing kidney disease
Hearing loss
Significant neuropathy
Poor performance status
Previous platinum chemotherapy
Significant electrolyte abnormalities
Other conditions or medications that may increase kidney injury

This does not necessarily mean cisplatin cannot be used.

It means the risk-benefit calculation may be different.

How Can Cisplatin Toxicity Be Reduced?

There is no way to eliminate cisplatin toxicity completely.

However, supportive care can reduce some risks.

Important strategies include:

Before treatment

Review kidney function
Review medications
Check electrolytes
Assess baseline neurological symptoms
Consider baseline hearing evaluation when appropriate
Discuss fertility preservation when relevant

During treatment

Adequate hydration
Monitoring kidney function
Monitoring electrolytes
Monitoring blood counts
Preventive anti-nausea medication
Monitoring neurological symptoms
Monitoring hearing when appropriate

After treatment

Continue to report persistent or worsening:

Numbness
Tingling
Hearing changes
Tinnitus
Kidney problems
Fatigue
Fertility concerns

Long-term follow-up is particularly important for patients treated with curative intent.

Does Cisplatin Cause Secondary Cancer?

Like some other DNA-damaging cancer treatments, cisplatin carries a potential risk of secondary malignancy.

The FDA prescribing information lists secondary acute leukemia among potential adverse effects.

This is an important consideration—but it needs to be placed in context.

For a patient with a highly curable cancer, the potential long-term risk of a treatment-related malignancy may be very small compared with the immediate danger posed by untreated cancer.

Again, this is a question of risk versus benefit, not simply risk.

The Cisplatin Risk-Benefit Question

For cancer patients, perhaps the most important point is this:

Cisplatin is neither “good” nor “bad.”

It is a powerful cancer treatment with potentially serious toxicity.

For some cancers and some patients, the potential benefit is enormous.

For others, a different treatment may offer a better balance between effectiveness and toxicity.

The appropriate question is therefore not:

“Is cisplatin dangerous?”

It is.

The better question is:

“For my cancer, how much additional benefit does cisplatin provide, and how does that benefit compare with my individual risk of toxicity?”

That is the question patients should discuss with their oncology team.

10 Questions to Ask Before Starting Cisplatin

Consider asking your oncologist:

Why is cisplatin being recommended for my cancer?
Is the goal cure, reducing recurrence risk, controlling cancer, or relieving symptoms?
How much benefit does cisplatin add to my treatment regimen?
What is my individual risk of kidney damage?
Should I have a baseline hearing test?
What is my risk of permanent neuropathy?
How will my kidney function and electrolytes be monitored?
How will nausea and vomiting be prevented?
Could carboplatin or another treatment be substituted—and if so, what would I potentially give up in terms of cancer control?
If I am receiving curative treatment, what long-term side effects should I monitor after chemotherapy ends?

PeopleBeatingCancer Perspective

Cisplatin illustrates an important principle of cancer treatment:

The effectiveness of a therapy cannot be separated from its toxicity.

A treatment that dramatically increases the probability of cure may be worth substantial short-term toxicity.

But patients should also ask whether there are evidence-based ways to reduce that toxicity without compromising the anticancer benefit.

This is especially important with cisplatin because several of its potential adverse effects—including kidney injury, neuropathy and hearing loss—can have consequences extending beyond the final chemotherapy infusion.

The goal should therefore be neither to automatically accept nor automatically reject cisplatin.

The goal is informed treatment.

Understand the expected benefit.

Understand the potential harm.

Understand how toxicity will be monitored.

Understand what alternatives exist.

Then make the decision with your oncology team based on your cancer and your priorities.

PeopleBeatingCancer Evidence Rating

Cisplatin issue	Evidence strength	What patients should know
Anticancer activity	Established	Cisplatin is a foundational platinum chemotherapy with proven activity across multiple cancers.
Curative potential in selected cancers	Established	Particularly important in several germ-cell/testicular cancer settings.
Kidney toxicity	Established	A major, dose-related and potentially serious toxicity.
Peripheral neuropathy	Established	Can be cumulative and sometimes persistent.
Hearing loss/tinnitus	Established	Cisplatin is a well-established cause of ototoxicity.
Nausea/vomiting	Established	Significant risk, but modern antiemetic therapy can substantially improve control.
Electrolyte abnormalities	Established	Magnesium and other electrolyte abnormalities can occur.
Hydration for kidney protection	Established supportive-care principle	Hydration is an important component of cisplatin administration.
Magnesium/mannitol for nephroprotection	Promising/clinical supportive evidence	Evidence supports their use in selected protocols, but approaches vary.
Otoprotective treatments	Preliminary/uncertain in adults	Research continues; no universally established adult strategy eliminates hearing toxicity.
Supplements to prevent cisplatin toxicity	Insufficient evidence	Patients should not assume that an antioxidant or supplement is safe or effective simply because it is “natural.”

Research and References

Cisplatin mechanism and resistance

Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene.
PubMed research record

Cisplatin and platinum drugs

Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nature Reviews Drug Discovery.
PubMed research record

Cisplatin kidney toxicity and supportive care

The Prevention of Cisplatin-Induced Nephrotoxicity: A General Consensus Statement.
Full-text research article

Cisplatin hydration

Hydration Methods for Cisplatin-Containing Chemotherapy: A Systematic Review.
PubMed research record

Cisplatin hearing loss

Dillard LK et al. Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.
PubMed research record

2025 systematic review of hearing-loss prevention

Briggs EE et al. Preventing Cisplatin-Induced Hearing Loss in Adults: A Systematic Review and Meta-Analysis.
PubMed research record

FDA prescribing information

The current cisplatin prescribing information provides detailed warnings regarding nephrotoxicity, neuropathy, nausea/vomiting, myelosuppression, ototoxicity and other adverse effects.
Current DailyMed cisplatin prescribing information

To learn more-

Our Mission